WA1
AGN

Wimmer Associates 1’s Allergan plc AGN Stock Holding History

Wimmer Associates 1’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,575
Closed -$626K – 112
2017
Q2 		$626K Sell
2,575
-30
-1% -$7.05K 0.58% 53
2017
Q1 		$622K Buy
2,605
+720
+38% +$168K 0.58% 54
2016
Q4 		$396K Sell
1,885
-270
-13% -$55.9K 0.37% 80
2016
Q3 		$496K Sell
2,155
-70
-3% -$17.1K 0.45% 65
2016
Q2 		$514K Buy
+2,225
New +$513K 0.46% 62

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Wimmer Associates 1's AGN Position: Q3 2017 in Review

Wimmer Associates 1 sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 2,575 shares — an estimated $626K sold.

Wimmer Associates 1 first reported a position in AGN in Q2 2016 and held it in 5 quarters. The position peaked at $626K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Wimmer Associates 1 reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Wimmer Associates 1 sold 2,575 Allergan plc shares in Q3 2017, an estimated $626K.
  • Wimmer Associates 1 first reported a position in Allergan plc in Q2 2016 and held it in 5 quarters.
  • Wimmer Associates 1's Allergan plc position peaked at $626K in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Wimmer Associates 1's 13F filing for Q3 2017, filed 14 Nov 2017.